IP Library Granted Patent US 10,087,153
Granted Patent B2
US 10,087,153 · App. 15/387,017 · Granted Oct 2, 2018

Method of preparing diaminophenothiazinium

Inventors: John V. Frangioni (Wayland, MA); Paul Caffrey (North Falmouth, MA)
Assignee: Curadel, LLC
C07D279/20
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,087,153
App. No.
15/387,017
Granted
Oct 2, 2018
Kind
B2
Abstract

Disclosed herein are methods for preparing ultrapure diaminophenothiasinium compounds with high solubility in solutions, e.g., water, and the compositions provided therefrom.

Claims (45)

1. A method of preparing an ultrapure diaminophenothiasinium compound with increased solubility in water, the method comprising lyophilizing at least one diaminophenothiasinimum compound from a solvent solution.

2. The method of claim 1 , further comprising, prior to lyophilization:

adding the at least one diaminophenothiasinium compound to a water-MeOH mixture with a water to MeOH ratio in a range of about a 3:1 to about 1:3;

passing the diaminophenothiasinium compound solution through a gradient with mobile phases of about 5 mM to about 20 mM HCl in water (e.g., 12 mM) and about 4 mM to about 20 mM HCl in MeOH (e.g., 12 mM);

collecting fractions;

concentrating the diaminophenothiasinium compound containing fraction;

dissolving the concentrated diaminophenothiasinium compound fraction in the solvent;

performing centrifugation on the concentrated diaminophenothiasinium compound(s) solvent solution; and

filtering the centrifuged diaminophenothiasinium compound(s) to prepare a ultrapure diaminophenothiasinium compound with high solubility.

3. The method of claim 1 , wherein the at least one compound is of the Formula (I) and/or its equivalent resonant structures (as described below):

wherein:

each of R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 and R 10 is independently selected from the group consisting of: a hydrogen atom ; saturated or unsaturated, linear, branched or cyclic C 1 -C 6 alkyl groups, optionally substituted with one or more functions chosen from a halogen atom, and a C 1 -C 6 alkoxy, C 1 -C 6 alkyloxycarbonyl or —CONH 2 function, aryl groups optionally substituted with one or more functions chosen from: a C 1 -C 4 alkyl, a halogen atom, and a C 1 -C 6 alkoxy, C 1 -C 6 alkyloxycarbonyl or —CONH 2 function;

R 6 and R 7 can be independently selected from methyl, ethyl, or —OH;

R 5 -R 10 can be independently selected from the halogen atoms: F, Cl, Br and I;

Z is an atom selected from O or S; and

X − represents an organic or inorganic anion.

4. The method of claim 3 , wherein X − is selected from: anions of inorganic acids; anions of organic acids; and OH − .

5. The method of claim 2 , further comprising producing a saturated DMSO solution with the ultrapure diaminophenothiasinium compound with high solubility.

6. The method of claim 5 , wherein the saturated DMSO solution of ultrapure diaminophenothiasinium compound with high solubility has a concentration in a range of about 18 mg/mL to about 22 mg/mL .

7. The method of claim 1 , wherein the ultrapure diaminophenothiasinium compound with high solubility is capable of producing a solution in water with a concentration greater than or equal to about 10 mg/mL.

8. The method of claim 2 , wherein filtering the centrifuged diaminophenothiasinium compound(s) is performed with a filter with pores in a range of about 0.22 μm to about 0.8 μm.

9. The method of claim 8 , wherein the pores are about 0.45 μm.

10. The method of claim 1 , wherein the solvent comprises DMSO.

11. The method of claim 10 , wherein the solvent further comprise a co-solvent.

12. The method of claim 11 , wherein the co-solvent is selected from acetic acid, acetone, acetonitrile, benzene, 1-butanol, 2-butanol, 2-butanone, t-butyl alcohol, carbon tetrachloride, chlorobenzene, chloroform, cyclohexane, 1,2-dichloroetane, diethylene glycol, diethyl ether, diglyme, 1,2-dimethoxy-ethane, dimethyl-formamide, 1,4-dioxane, ethanol ethyl acetate, ethylene glycol, glycerin, heptane, hemamethylphophoramie, hexamethylphosphorous triamide, hexane, methanol, methyl t-butyl ether, methylene chloride, N-methyle-2-pyrrolidinone, nitromethane, pentane, petroleum ether, 1-propanol, 2-propanol, pyridine, tetrahydrofuran, toluene, triethyl amine, o-xylene, m-xylene, p-xylene, or any combination thereof.

13. The method of claim 10 , wherein the solvent further comprises a lyophilization excipient.

14. The method of claim 13 , wherein the lyophilization excipient includes at least one of acetic acid, detran, glucose, glycine, hexose, histidine, lactose, L-arginine, mannitol, polyethylene glycol, PVP (K40), raffinose, sorbitol, sucrose, and trehalose.

15. A composition comprising: at least one diaminophenothiasinium compound with a solubility in water of greater than or equal to about 10 mg/mL.

16. The composition of claim 15 , wherein the at least one diaminophenothiasinium compound has a Formula (I):

wherein:

each of R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 and R 10 is independently selected from the group consisting of: a hydrogen atom; saturated or unsaturated, linear, branched or cyclic C 1 -C 6 alkyl groups, optionally substituted with one or more functions chosen from a halogen atom, and a C 1 -C 6 alkoxy, C 1 -C 6 alkyloxycarbonyl or —CONH 2 function, aryl groups optionally substituted with one or more functions chosen from: a C 1 -C 4 alkyl, a halogen atom, and a C 1 -C 6 alkoxy, C 1 -C 6 alkyloxycarbonyl or —CONH 2 function;

R 6 and R 7 can be independently selected from methyl, ethyl, or —OH;

R 5 -R 10 can be independently selected from the halogen atoms: F, Cl, Br and I;

Z is an atom selected from O or S; and

X − represents an organic or inorganic anion.

17. The composition of claim 16 , wherein X − is selected from: anions of inorganic acids; anions of organic acids; and OH − .

18. A method of preparing an ultrapure diaminophenothiasinium compound with increased solutibility in water, the method comprising:

adding the at least one diaminophenothiasinium compound to a water-MeOH mixture with a water to MeOH ratio in a range of about a 3:1 to about 1:3;

passing the diaminophenothiasinium compound solution through a gradient with mobile phases of about 5 mM to about 20 mM HCl in water (e.g., 12 mM) and about 4 mM to about 20 mM HCl in MeOH (e.g., 12 mM);

collecting fractions;

concentrating the diaminophenothiasinium compound containing fraction;

dissolving the concentrated diaminophenothiasinium compound fraction in the solvent;

performing centrifugation on the concentrated diaminophenothiasinium compound(s) solvent solution;

filtering the centrifuged diaminophenothiasinium compound(s) to prepare a ultrapure diaminopheno thiasinium compound with high solubility; and

lyophilizing at least one diaminophenothiasinimum compound from a solvent solution.

Assignments (2)
CONFIRMATORY LICENSE Recorded Aug 21, 2023
From: CURADEL, LLC
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 064657/0294 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 30, 2018
From: CAFFREY, PAUL; FRANGIONI, JOHN V.
To: CURADEL, LLC
Reel/Frame 046981/0548 →
Continuity (2)
Provisional Application 62271507 · Dec 28, 2015
Related Publication 20170183320A1 · Jun 29, 2017